(Reuters) - Roche Holding AG's planned $8 billion purchase of InterMune Inc is centered around hopes for blockbuster sales of its lung drug, but the smaller company's development pipeline may end up giving the Swiss drugmaker a far bigger bang for its buck.

Topics:  reuters    roche holding ag   intermune inc   swiss   drug   big   
BING NEWS:
  • J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade
    Johnson & Johnson, Roche, and AstraZeneca are set to become the top 3 orphan drugmakers by sales in 2028. Read more here.
    04/28/2024 - 6:00 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News